Gene · 7006
Papers1,477
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,477
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic Analysis of Prehypertensive and Hypertensive Patients: Exploring the Role of the Actin Cytoskeleton. | Int J Mol Sci | 2024 | 38732116 | PubTator, text mining | PubMed |
| Interaction of T-cell-specific adapter protein with Src- and Tec-family kinases. | Scand J Immunol | 2024 | 38605535 | PubTator, text mining | PubMed |
| Moving Beyond Boundaries: Utilization of Longitudinal Exposure-Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm. | Clin Pharmacokinet | 2024 | 38358645 | PubTator, text mining | PubMed |
| Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia. | Blood Adv | 2024 | 38306602 | PubTator, text mining | PubMed |
| Intraepithelial Inclusions on Urinalysis Screening among COVID-19 Cases: Are they Covicytes?-A Hospital-Based Cohort Study with Narrative Review. | J Cytol | 2024 | 38282809 | PubTator, text mining | PubMed |
| Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program. | Am J Clin Dermatol | 2024 | 38263353 | PubTator, text mining | PubMed |
| MicroRNAs Associated with a Bad Prognosis in Acute Myeloid Leukemia and Their Impact on Macrophage Polarization. | Biomedicines | 2024 | 38255226 | PubTator, text mining | PubMed |
| Location, location, location: Protein kinase nanoclustering for optimised signalling output. | Elife | 2024 | 38206309 | PubTator, text mining | PubMed |
| DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance. | Nat Commun | 2024 | 38177131 | PubTator, text mining | PubMed |
| European expert consensus statement on the systemic treatment of alopecia areata. | J Eur Acad Dermatol Venereol | 2024 | 38169088 | PubTator, text mining | PubMed |
| Baseline Serum and Stool Microbiome Biomarkers Predict Clinical Efficacy and Tissue Molecular Response After Ritlecitinib Induction Therapy in Ulcerative Colitis. | J Crohns Colitis | 2024 | 38141256 | PubTator, text mining | PubMed |
| Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey. | Dermatol Ther (Heidelb) | 2024 | 38079099 | PubTator, text mining | PubMed |
| Integrase-associated niche differentiation of endogenous large DNA viruses in crustaceans. | Microbiol Spectr | 2024 | 38063384 | PubTator, text mining | PubMed |
| The basis of S-R learning: associations between individual stimulus features and responses. | Psychol Res | 2024 | 37721559 | PubTator, text mining | PubMed |
| Target Occupancy and Functional Inhibition of JAK3 and TEC Family Kinases by Ritlecitinib in Healthy Adults: An Open-Label, Phase 1 Study. | J Clin Pharmacol | 2024 | 37691236 | PubTator, text mining | PubMed |
| Optical sensing and control of T cell signaling pathways. | Front Physiol | 2023 | 38269062 | PubTator, text mining | PubMed |
| Comparison of Transcriptomic Analysis of the Conjunctiva in Glaucoma-Treated Eyes with Dry Eyes and Healthy Controls. | Biomolecules | 2023 | 38254630 | PubTator, text mining | PubMed |
| Vitiligo: Current Therapies and Future Treatments. | Dermatol Pract Concept | 2023 | 38241396 | PubTator, text mining | PubMed |
| LIMS-Kinase provides sensitive and generalizable label-free in vitro measurement of kinase activity using mass spectrometry. | Cell Rep Phys Sci | 2023 | 38213501 | PubTator, text mining | PubMed |
| Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib. | J Clin Med | 2023 | 38202039 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7006/papers?page=5